Table 2.
Prediction of CTL epitopes that possess a binding affinity to MHC-I A1-supertype alleles, C-terminal cleavage affinity, transport efficiency, antigenic, non-allergenic, and non-toxic to be considered for the vaccine construct
| Peptide | Antigenicity | Allergenicity | Toxicity | Start position | Predicted score |
|---|---|---|---|---|---|
| TVSVIDPTTNTVTGSP |
0.4492 (probable antigen) Predicted probability of antigenicity: 0.257455 |
Non-allergen | Non-toxin | 283 | 0.93 |
| VSLARAGTAGGAGRGP |
1.3660 (probable antigen) Predicted probability of antigenicity: 0.286939 |
Non-allergen | Non-toxin | 174 | 0.93 |
| TGVAVNPVTGEVYVTN |
0.7489 (probable antigen) Predicted probability of antigenicity: 0.623258 |
Non-allergen | Non-toxin | 306 | 0.90 |
| GGVGGAGGAAGAVTTI |
2.1353 (probable antigen) Predicted probability of antigenicity: 0.663254 |
Non-allergen | Non-toxin | 197 | 0.90 |